Related Experiment Video
Updated: Aug 8, 2026
14:48
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Angiopoietin-2 levels are elevated in exudative pleural effusions
Ioannis Kalomenidis1, Androniki Kollintza, Ioanna Sigala
1Marianthi Simou Laboratory, Department of Critical Care and Pulmonary Services, Athens Medical School, "Evangelismos" Hospital, 45-47 Ipsilandou St, 10675 Athens, Greece. jkalomenidis@hotmail.com
Chest
|May 11, 2006
Summary
Angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF) are elevated in exudative pleural effusions (PEs), correlating with inflammation markers. Ang-1 levels do not differ significantly in PEs.
Area of Science:
- Biochemistry and Molecular Biology
- Pulmonology and Respiratory Medicine
- Oncology (for malignant PEs)
Background:
- Pleural effusions (PEs) are fluid accumulations in the pleural space, categorized as transudative or exudative.
- Exudative PEs often indicate underlying inflammation or malignancy, necessitating accurate diagnostic markers.
- Angiopoietins (Ang-1, Ang-2) and vascular endothelial growth factor (VEGF) are key regulators of angiogenesis and vascular permeability.
Purpose of the Study:
- To quantify and compare pleural fluid (PF) and serum levels of Ang-1, Ang-2, and VEGF in patients with various types of PEs.
- To investigate the relationship between these growth factors and the characteristics of different pleural effusion etiologies.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure PF and serum levels of Ang-1, Ang-2, and VEGF.
- The study included 115 patients with transudative (heart failure) and exudative (malignant, parapneumonic, tuberculous, miscellaneous) PEs.
- Statistical analyses were performed to compare levels between groups and assess correlations with clinical parameters.
Main Results:
- PF Ang-2 and VEGF levels were significantly higher in exudative PEs compared to transudative PEs.
- Tuberculous PEs showed the highest PF Ang-2 levels, while heart failure PEs had the lowest.
- PF Ang-2 levels correlated positively with VEGF, red blood cell count, nucleated cell count, total protein, and lactate dehydrogenase.
Conclusions:
- Elevated Ang-2 levels in exudative PEs, correlating with VEGF and inflammation markers, suggest a role in pleural inflammation and pathogenesis.
- Ang-2, but not Ang-1, appears to be a significant factor in the development of exudative pleural effusions.
- VEGF levels varied by etiology, being highest in malignant and parapneumonic PEs and lowest in transudates.
Related Concept Videos
01:25Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:26Endoscopic Studies II: Thoracocentesis
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.